Concerns Rise Among Diabetes Patients Over Novo Nordisk's New Insulin Pricing and Strategy

The recent announcement by Novo Nordisk regarding its plans to alter the pricing and availability of insulin has sent waves of anxiety through the diabetes community. This change comes at a time when many patients are already struggling with the financial burdens associated with managing their chronic condition.

Continue reading